Down Syndrome Diagnosis: Sequenom Moves Closer To Noninvasive Test

Sequenom has made progress towards being first-to-market with a blood test to replace invasive prenatal Down syndrome diagnostics despite a challenge along the way from an upstart group out of Stanford University